GNH USA

Europe — EMA

Noradrenalin Ligula Pharma (Noradrenaline Tartrate)

GNH USA supplies Noradrenalin Ligula Pharma (Noradrenaline), a vasopressor for acute hypotension, septic shock and cardiac arrest.

Noradrenaline Tartrate

Request sourcing

1
Pack/s

What is Noradrenaline Tartrate?

Noradrenaline tartrate, the active ingredient in Noradrenalin Ligula Pharma, is a sympathomimetic agent presented as an injectable solution for intravenous use. Manufactured under EU GMP standards, it is employed to raise blood pressure in acute hypotension, support circulation in septic shock, and assist resuscitation during cardiac arrest in emergency and critical care settings.

GNH USA supplies Noradrenalin Ligula Pharma as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals worldwide.

What is Noradrenaline Tartrate used for?

Noradrenalin Ligula Pharma is used in critical care to manage severe circulatory failure.

- Acute hypotension: rapidly increases systemic vascular resistance to restore adequate blood pressure. - Septic shock: improves hemodynamic stability by counteracting vasodilatory shock. - Cardiac arrest: provides essential vasoconstrictive support during advanced cardiac life support.

What are the side effects of Noradrenaline Tartrate?

Noradrenalin Ligula Pharma may be associated with a range of adverse reactions, varying from frequent to rare but serious.

Common Side Effects: - Tachycardia - Hypertension - Headache - Nausea - Anxiety - Tremor

Serious or Rare Side Effects: - Myocardial ischemia - Severe arrhythmias - Peripheral tissue necrosis at injection site - Pulmonary edema - Extreme hypertension leading to cerebrovascular hemorrhage

What precautions apply to Noradrenaline Tartrate?

When using Noradrenalin Ligula Pharma, careful monitoring and specific precautions are essential to ensure patient safety.

- Blood pressure monitoring: continuously assess arterial pressure and adjust infusion rate accordingly. - Dose titration: titrate to the lowest effective dose to achieve target hemodynamics. - Coronary artery disease: use with caution in patients with known ischemic heart disease. - Concomitant beta‑blockers: anticipate reduced efficacy and consider alternative support. - Pheochromocytoma: contraindicated due to risk of hypertensive crisis. - Store at 2-8°C: keep refrigerated, protect from light, do not freeze or shake.

What does Noradrenaline Tartrate interact with?

Noradrenalin Ligula Pharma can interact with several drug classes, requiring attention to avoid harmful effects.

Major Interactions (Avoid): - Monoamine oxidase inhibitors: may precipitate severe hypertensive episodes. - Tricyclic antidepressants: increase risk of hypertension and arrhythmias. - Beta‑blockers: can blunt the desired pressor response. - Clonidine withdrawal: may cause rebound hypertension when combined.

Moderate Interactions (Monitor Closely): - Calcium channel blockers: may enhance vasoconstrictive effect, requiring dose adjustment. - Diuretics: can potentiate intravascular volume depletion, affecting response. - Other vasopressors: concurrent use may lead to excessive vasoconstriction. - Anesthetic agents (e.g., halothane): may alter cardiovascular response.

Frequently asked questions

What is Noradrenalin Ligula Pharma used for?+
Noradrenalin Ligula Pharma is an injectable vasopressor used in hospital settings to treat acute hypotension, manage septic shock, and provide circulatory support during cardiac arrest. It is administered intravenously by qualified healthcare professionals to rapidly raise blood pressure and improve organ perfusion in emergency and critical care situations.
How does noradrenaline work in the body?+
Noradrenaline acts as a direct agonist at α1‑adrenergic receptors, causing strong vasoconstriction that increases systemic vascular resistance, and at β1‑adrenergic receptors, enhancing heart contractility and rate. The combined effect raises arterial pressure and cardiac output, helping to restore adequate tissue perfusion during severe circulatory failure.
What is the usual dose of Noradrenalin Ligula Pharma?+
The specific dose of Noradrenalin Ligula Pharma is determined by the treating physician based on the patient’s clinical condition, blood pressure response, and desired therapeutic goal. It is delivered as an intravenous infusion that is titrated in real‑time to achieve target hemodynamic parameters, with dosing adjustments made by the medical team.
Is Noradrenalin Ligula Pharma safe in pregnancy or breastfeeding?+
Safety data for noradrenaline in pregnancy and lactation are limited, and the product is classified as having an unknown pregnancy category. It should only be used when the potential benefit to the mother outweighs any possible risk to the fetus or infant, and the decision must be made by the prescribing clinician.
How do I order Noradrenalin Ligula Pharma from GNH USA?+
To place an order, submit an enquiry on the product page at gnh-usa.com, specifying the required quantity. GNH USA works with hospitals, pharmacies, and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details (including cold‑chain logistics if needed), and any required import documentation.
How does Noradrenalin Ligula Pharma compare with other vasopressors?+
Noradrenaline is generally preferred over dopamine for most shock states because it provides potent α1‑mediated vasoconstriction with less tachyarrhythmia risk. Compared with epinephrine, it has a stronger vascular effect and a weaker β2‑mediated metabolic impact, making it suitable for sustained blood‑pressure support while minimizing excess heart‑rate acceleration.
What are the storage and handling requirements for Noradrenalin Ligula Pharma?+
The product must be stored at 2‑8 °C in a refrigerator, protected from light, and should never be frozen or shaken. It should be kept in its original packaging until use, and any unused portion must be discarded according to local regulations after the recommended in‑use period.
How is Noradrenalin Ligula Pharma administered?+
Noradrenalin Ligula Pharma is administered intravenously, typically as a continuous infusion. The infusion is started at a low rate and titrated upward based on real‑time blood‑pressure measurements and clinical response, under the supervision of trained medical personnel in an intensive‑care or emergency environment.
What are the most serious risks associated with Noradrenalin Ligula Pharma?+
Serious risks include myocardial ischemia, severe arrhythmias, extreme hypertension that can lead to cerebrovascular hemorrhage, and peripheral tissue necrosis at the infusion site. Continuous hemodynamic monitoring and prompt adjustment of the infusion rate are essential to mitigate these potentially life‑threatening complications.
Who should not receive Noradrenalin Ligula Pharma?+
Patients with known pheochromocytoma, uncontrolled hypertension, or severe peripheral vascular disease should not receive noradrenaline due to the high risk of exacerbating these conditions. Additionally, individuals with hypersensitivity to noradrenaline or any excipients in the formulation should avoid its use.
Information provided on this page is for educational use by procurement and clinical professionals. Always consult a licensed healthcare provider for medical advice and prescribing decisions. GNH USA supplies this product subject to applicable regulatory and licensing requirements.
Send a sourcing enquiry for this product →

Product details

Drug
Noradrenaline Tartrate
Route
Intravenous Use
Manufacturer
Ligula Pharma D.O.O.
Origin
EU

Related products

Cronomir

Cronomir

Noradrenaline Tartrate

Laboratoire Aguettant
EU
L-Noradrenalina Braun

L-Noradrenalina Braun

Noradrenaline Tartrate

B. Braun Medical Lda.
EU
Levophed

Levophed

Noradrenaline Tartrate

Hospira Benelux
EU
Levophed

Levophed

Noradrenaline Tartrate

Hospira Benelux
EU